Apoptosis and necrosis represent distinct cell death processes that regulate mammalian development, physiology and disease. Apoptosis characteristically leads to the silent destruction and removal of cells in the absence of an inflammatory response. In contrast, necrotic cell death can induce physiological inflammatory responses linked to tissue defence and repair. Although anucleate, platelets undergo programmed cell death, with apoptosis playing an important role in clearing effete platelets from the circulation. Whilst it has long been recognized that procoagulant platelets exhibit characteristic features of dying cells, recent studies have demonstrated that platelet procoagulant function can occur independent of apoptosis. A growing body of evidence suggest that the biochemical, morphological and functional changes underlying agonist-induced platelet procoagulant function are broadly consistent with cell necrosis, raising the possibility that distinct death pathways regulate platelet function and survival. In this perspective we will discuss the mechanisms underlying apoptotic and necrotic cell death pathways and examine the evidence linking these pathways to the platelet procoagulant response. We will also discuss the potential contribution of these pathways to the platelet storage lesion and propose a simplified nomenclature to describe procoagulant platelets.
Introduction
Up until the early 1970's it was thought that all cells die as a result of necrosis (Table 1) ; a form of cell death that is prominent when tissues undergo extensive damage from trauma or disease. This concept changed dramatically in 1972 following the landmark observations of Kerr and colleagues 1 who described a new form of cell death, termed apoptosis (Table 1) .
Since then, the genetic and biochemical processes responsible for apoptotic cell death have been extensively investigated. It is now well defined that apoptosis is a key process underlying human development, normal physiology and a range of common human diseases 2 .
In contrast, the concepts underlying necrosis have become less clear-cut. Whilst it has long been assumed that necrosis is predominantly a pathological process resulting from tissue injury, there is growing evidence that cells can orchestrate their own demise through programmed cell necrosis in a manner that initiates physiological inflammatory and repair responses [3] [4] [5] [6] [7] [8] .
Although anucleate, platelets have the capacity to undergo programmed cell death (Table 1) .
This has been most clearly demonstrated with platelet apoptosis; a process that is important for clearance of effete platelets from the circulation [9] [10] . Many of the features of apoptosis (membrane fragmentation, cytoskeletal disruption, microvesiculation, caspase activation and phosphatidylserine exposure) are observed during prolonged platelet storage ex vivo and during the conversion of activated platelets to a procoagulant state, raising the possibility that apoptosis may also regulate platelet function. However, recent studies have demonstrated that the molecular events underlying agonist-induced platelet procoagulant function can occur independently of apoptotic cell death 11 , raising the possibility that alternative cell death pathways contribute to platelet procoagulant function (Table 1) .
Distinct biochemical processes regulate apoptosis and necrosis
Based on studies in nucleated cells, distinct molecular processes regulate the fate of apoptotic and necrotic cells. Morphologically, apoptosis is characterised by cell shrinkage, nuclear condensation and fragmentation, and the formation of condensed cell bodies. Central to apoptosis are the caspase family of cysteine proteases. Caspases dismantle the cell from within, executing their demise through restricted proteolysis of key cellular structures, resulting in cytoskeletal disassembly, plasma membrane instability (leading to blebbing), proteolytic processing of cell surface receptors (undermining cell adhesion), and through the . Central to this process is the balance between prosurvival proteins (such as Bcl-X L ) and pro-apoptotic molecules (i.e. Bak/Bax). Functional loss of Bcl-X L liberates Bak/Bax to form oligomers in the outer mitochondrial membrane, leading to mitochondrial outer membrane permeabilization (MOMP) 13 and release of cytochrome C (CytC). Once released from the mitochondria, CytC initiates apoptosome assembly and caspase activation ( Figure 1) .
Notably, the process of apoptosis is energy-dependent with apoptotic cells maintaining the integrity of their plasma membrane, minimising disruption to neighbouring cells and avoiding unwanted immune responses.
In contrast to apoptosis, necrosis is typified by bioenergetic failure of the cell (ATP depletion), leading to rapid loss of plasma membrane integrity and the release of cellular contents into the extracellular environment. Also referred to as 'oncosis' (based on the Greek term ónkos meaning swelling) necrotic cell death is characterized by swelling of cytoplasmic organelles and the plasma membrane, ultimately leading to cell lysis. Several defined molecular events underlie the necrotic process, with calcium (Ca Calcium cytotoxicity and ATP depletion contribute to cell damage by promoting excess mitochondrial ROS production. In addition to oxidative modification of DNA and proteins, ROS are highly reactive to lipids, leading to loss of integrity of both the plasma membrane and intracellular membranes, including the lysosomes and ER. Subsequent leakage of 
Dysregulated calcium flux and cell death
One of the cardinal features of necrotic cell death is dysregulated intracellular calcium flux 4 .
High, sustained cytosolic calcium levels are toxic to the cell, leading to activation of intracellular proteases, damage to the mitochondria and ultimately disruption of organelles and the plasma membrane 4,15 . Therefore to fulfil its intracellular second messenger function, calcium signals must typically be transient or oscillatory in nature [16] [17] . To prevent calcium toxicity, mammalian cells have evolved a complex network of calcium channels that rapidly remove calcium from the cytosol into specialized storage compartments or to the extracellular space [16] [17] [18] . Dysregulated calcium homeostasis is also a feature of apoptosis, however the levels of calcium required to trigger apoptosis are typically lower than those that induce necrosis 4 .
In the context of necrosis, bioenergetic failure and dysregulated Ca 2+ homeostasis act in a cooperative manner to enhance organelle damage and cell death. Many of the channels linked to the control of intracellular Ca 2+ levels, including the Plasma Membrane ATPase (PMCA) and the Sarcoplasmic Endoreticulum Ca 2+ ATPase (SERCA), are ATP-dependent, such that following an initial Ca 2+ insult, the subsequent mitochondrial damage and ATP depletion exacerbate elevated intracellular Ca 2+ levels.
Agonist-induced procoagulant platelets -apoptotic or necrotic?
A fundamental, but incompletely understood aspect of platelet function is the relationship between a regulated, naturally occurring platelet activation response i.e. platelet procoagulant function, and the cell death pathways regulating platelet survival. In this context, procoagulant platelets are not just highly activated cells, they are undergoing cell death. They have all the biochemical, morphological and functional features of a dying cell, including caspase and calpain activation, proteolytic processing of cytoskeletal elements, surface exposure of phosphatidylserine (PS), membrane contraction, blebbing and microvesiculation.
Morphologically, procoagulant platelets have lost their internal organelles, their cytoskeleton is completely disrupted and functionally these platelets have lost their ability to adhere and .
There is a growing body of evidence demonstrating that many of the biochemical processes regulating agonist-induced platelet procoagulant function are more typical of necrosis ( Figure   3 , raising the possibility that they play an important physiological role in promoting leukocyte recruitment/activation at sites of vascular injury. These functional properties of procoagulant platelets are broadly consistent with the role of cell necrosis in signaling physiological inflammatory and repair responses.
Procoagulant platelets -Searching for their real identity
Since both apoptotic and necrotic death pathways can lead to surface PS-exposure and a procoagulant platelet surface, an accurate description of agonist-induced procoagulant platelets is required to differentiate these platelets from other potential procoagulant forms. Balloon-shaped procoagulant platelets -A hallmark feature of procoagulant platelets that readily distinguishes them from other forms of activated platelets is their adoption of a 'balloon-like' appearance ( Figure 4 ). The dynamic changes in platelet morphology during transformation from an activated to a procoagulant state were first observed by Heemskerk and colleagues using high resolution phase contrast imaging [35] [36] . Phenotypic conversion of spread platelets to a procoagulant state is associated with contraction of the cell membrane, membrane bleb formation and ballooning, as well as microvesiculation from the cell surface.
This dramatic morphological conversion is associated with loss of membrane phospholipid asymmetry and the surface exposure of anionic phospholipids, particularly phosphatidylserine. As a consequence, all balloon-shaped platelets bind high levels of annexin Va. The combination of their distinct balloon-like appearance, combined with their ability to support coagulation reactions, led to their initial description as balloon-shaped procoagulant platelets [31] [32] [37] [38] .
COAT/COATED platelets -In unrelated studies, Dale and colleagues described a subset of platelets that express high levels of factor V on their surface following potent platelet stimulation with thrombin and collagen [33] [34] . Initially termed "COAT" platelets, these cells represent a subset of the platelet population that retain high levels of α-granule proteins on their surface, including factor V (FV), fibrinogen, fibronectin and von Willebrand factor (VWF). Several of these proteins are derivatized with serotonin in a transglutaminasedependent fashion 33 , thereby creating a stabilized multivalent coating over the platelet surface. With the subsequent demonstration that these platelet subtypes could be generated by stimuli other than collagen and thrombin, the acronym COAT has been extended to COATED, reflecting the surface coating of these platelets by adhesive proteins and coagulation factors. Whether COATED platelets and balloon-shaped procoagulant platelets are one and the same remains unclear, however the ability of COATED platelets to expose PS and retain high levels of procoagulant proteins on their surface suggests a primary role for Given the acronyms of COAT, COATED platelets 34 and SCIP reflect only specific aspects of platelet procoagulant function, it may be more appropriate to classify agonist-induced procoagulant platelets (those that have undergone a high, sustained cytosolic calcium response) as procoagulant necrotic platelets (Table 1) , a term that may more accurately reflect the underlying molecular processes governing the cell's fate.
Apoptotic and necrotic death pathways -Implications for the platelet storage lesion
If platelets do have the capacity of undergoing more than one form of programmed cell death, what are the potential implications for the platelet storage lesion (PSL)? It has long been speculated that the 'shelf-life' of stored platelets is primarily regulated by platelet apoptosis 39 . . Apoptosis with ensuing "secondary necrosis" may therefore be relevant to the PSL. Consistent with this, metabolic disturbance has been reported to play a role in the loss of platelet viability during PSL [41] [42] [43] [44] [45] [46] .
The possibility of stored platelets undergoing secondary necrosis may partly explain the inability of apoptosis inhibitors to maintain the viability of stored platelet concentrates [47] [48] ..
Would agents that preserve mitochondrial function improve the viability of stored platelets?
Much of the current effort into improving the viability of stored platelet concentrates has focussed on reducing platelet activation, maintaining pH, buffering lactate production and enhancing gas exchange. This has been achieved with the use of platelet activation inhibitors (NO, phosphodiesterase inhibitors, apyrase and prostacyclin, protease inhibitors) [49] [50] [51] [52] [53] [54] [55] [56] , through
inclusion of additives such as acetate, phosphate, gluconate, potassium, and magnesium 40, [42] [43] [44] [45] [46] [57] [58] [59] and through the implementation of modified storage bags with agitation 60 . However, these measures have provided only modest improvements in platelet viability. This may not 1 1 be surprising given that these approaches only partially mitigate the consequences of mitochondria damage, and do not target the primary underlying cause of the PSL, namely irreversible mitochondrial injury (Shrivastava, 2009) [61] [62] [63] . Whether inhibitors of platelet activation and apoptosis, in combination with agents that preserve mitochondrial function (such as inhibitors of cyclophilin D), will further improve platelet viability, remains to be determined.
Perspectives and future directions
Significant advances in understanding the molecular events regulating procoagulant platelet function have occurred over the last decade, with a growing body of evidence demonstrating a central role for mitochondrial dysfunction in the induction of a procoagulant platelet response [25] [26] . In this context, the procoagulant platelet response is distinct from all other physiological platelet activation responses, in that it is primarily initiated by cell death pathways that produce fundamental alterations in platelet morphology, ultrastructure and function. V o x S a n g . V o x S a n g . 
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Apoptosis
Describes a process of programmed cell death employed to dispose of damaged, redundant or superfluous cells, wherein cells die silently and are removed by macrophages in the absence of inflammatory/reparative responses.
Apoptotic cell death pathway
Extrinsic (eg. Death receptor initiated) or intrinsic (eg. Bcl-2 family-mediated) biochemical signals result in caspase activation, leading to a series of well characterised morphological changes (including blebbing, loss of cell membrane asymmetry (PS exposure) and attachment, cell shrinkage, nuclear fragmentation, chromatin condensation, and chromosomal DNA fragmentation), and eventual cell death and clearance.
Note: In this perspective, we have limited our discussion of apoptotic cell death pathways to the intrinsic Bcl-2-mediated pathway implicated in the regulation of platelet lifespan 9 .
Necrosis
Describes an alternative form of programmed cell death 4,6-7 , often initiated following a chemical (hypoxia, glucose depletion, acidosis), heat-related or mechanical insult. Necrosis results in cell lysis, provoking inflammatory and reparative responses in surrounding cells and tissue.
Note: In this perspective, we refer to cell necrosis as opposed to tissue necrosis -being the drastic macroscopic tissue changes, visible to the naked eye occuring after cell death 70 .
Necrotic cell death pathway
Characterised by bioenergetic failure of the cell, followed by loss of plasma membrane integrity, cell and organelle swelling and cytolysis. These features are a consequence of a defined set of molecular events, including mitochondrial dysfunction (rapid loss of membrane potential, metabolic failure, increased ROS production), sustained toxic intracellular calcium levels and the activation of non-apoptotic proteases such as calpain and lysosomal cathepsins. A key modulator of the necrotic death pathway is the inner mitochondrial membrane protein cyclophilin D (CypD), which controls mitochondrial permeability transition (mPT).
Functional necrosis
Certain forms of necrotic cell death are now being reconsidered as normal physiological programmed cell events. By initiating adaptive responses, necrosis may be considered as an important response to maintain tissue and organism integrity through the initiation of inflammatory and reparative responses 3-8 .
Procoagulant platelets
Phosphatidylserine (PS)-positive platelets capable of facilitating thrombin generation.
Procoagulant apoptotic platelets
Platelets induced to become procoagulant through a Bak/Bax-mediated apoptotic signalling pathway, in a manner dependent upon caspases but independent of platelet activation and granule release.
Procoagulant necrotic platelets
Platelets induced to become procoaguant through potent activation, leading to high sustained levels of cytosolic calcium, rapid mitochondrial dysfunction, and loss of membrane integrity. These platelets are also capable of initiating an inflammatory response.
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